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Abstract
This thesis employs data mining techniques to discover domain knowledge in
epigenetic modification and gene expression profile. Computational methods
are developed for three research questions, namely, how to accurately
predict DNA N
4
-methylcytosine site, how to precisely identify mRNA N
6
-
methyladenosine sites, and how to identify lung cancer gene expression
profile markers. The motivations of the proposed methods are improving
the performance of computational methods via constructing e cient feature
space, optimizing machine learning schemes, solving the data imbalance




-methylcytosine (4mC) is a critical epigenetic modification and
plays various roles in the restriction-modification system. The computational
methods have been explored to identify 4mC in the DNA sequence in recent
years due to the high cost of experimental laboratory detection. However,
the state-of-the-art methods have limited performance because of the lack
of e↵ective sequence features and the ad hoc choice of learning algorithms.
Chapter 3 proposes a new method with novel sequence feature space and
machine learning scheme. In sequence encoding, five essential sequence
features are integrated into a 292-dimension feature space, representing both
global and local sequence characteristics. Then a feature selection scheme
is built, where the feature importance score produced from the training
process of XGBoost machine is taken as the criterion of feature selection.
At last, an SVM-based prediction model is trained with the selected features
xv
Abstract
and optimized by 10-fold cross-validations. In the result part, the impact
of feature selection on model performance is evaluated by an independent
test. The proposed method outperforms three state-of-art predictors in both
independent test and 10-fold cross-validation. Furthermore, two case studies





A) widely involves in mRNA metabolism and
embryogenesis. Multiple computational human mRNA m
6
A site predictors
have been developed. However, there are two main drawbacks of the existing
methods: first, inadequate learning of the imbalanced training data; second,
the sequence text features are not outstanding in representing m
6
A sequence
characteristics. Chapter 4 proposes to use the cost-sensitive learning idea to
solve the imbalance data issues in the problem. This cost-sensitive approach
learns from the entire imbalanced dataset without a random selection of
negative samples. In sequence representation, site location, entropy features
and specific single nucleotide polymorphism (SNP) positions are taken as new
features, which improve the performs significantly. In the comparison with
existing predictors, our method achieves better correctness and robustness in
both independent tests and case studies. The results suggest that imbalance
learning is promising to improve the performance of m
6
A prediction.
The early diagnosis of lung cancer has been a challenging problem in
clinical practice for a long time. The identification of di↵erentially expressed
genes as a disease marker is a promising solution. Chapter 5 presents
a novel approach to identify marker genes and define the boundary of
gene expression profile for human lung cancer. By calculating the kernel
maximum mean discrepancy, the proposed method evaluates the expression
di↵erence between normal, normal adjacent to tumor (NAT) and tumor
samples. The expression level boundaries among di↵erent groups are defined
with the information entropy theory for marker genes. Compared with two
conventional methods t-test and fold change, the genes selected by MMD
values have better performance under all metrics in 10-fold cross-validation.
Furthermore, the GO and KEGG enrichment analysis validate the discovered
xvi
Abstract
marker gene in function pathways. At last, we choose ten most meaningful
genes as lung cancer markers and calculate the expression profile boundaries.
The proposed method is more accurate than conventional DEA methods in
marker gene identification and provides a reliable method for defining the
gene expression level boundaries.
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